Scalable preparation of osteogenic micro-tissues derived from hESC-derived immunity-and-matrix-regulatory cells within porous microcarriers in suspension culture.
Ontology highlight
ABSTRACT: Bone defects (BDs), a prevalent clinically refractory orthopaedic disease, presently have no effective treatments. Mesenchymal stem cells (MSCs) can differentiate into osteoblasts and serve as potential seed cells for bone tissue engineering for BD treatment. However, the feasibility of using MSCs as seed cells for bone tissue engineering remains unclear. As a result, the critical issue of large-scale cell-scaffold preparation remains unresolved. In this study, we demonstrated for the first time that human embryonic stem cell-derived MSCs, also known as immunity-and-matrix-regulatory cells (IMRCs), could be inoculated into microcarriers to create osteogenic micro-tissues appropriate for scalable production in 250 mL bioreactor. IMRCs were generally smaller than umbilical cord-derived MSCs
SUBMITTER: Ma H
PROVIDER: S-EPMC10212705 | biostudies-literature | 2023 May
REPOSITORIES: biostudies-literature
ACCESS DATA